The FDA has approved Vtama cream 1% for atopic dermatitis in adults and children aged 2 years and older, Organon announced in a press release.
“Topical therapies remain a cornerstone for treating atopic dermatitis (AD) whether patients have mild, moderate or severe disease. But there remains an unmet need for safe, effective and tolerable non-steroidal topical therapies that can be used in both adults and pediatric patients,” Mona Shahriari, MD, assistant clinical professor of dermatology at Yale University School of Medicine, told Healio.
The FDA’s decision was based on data